Pharmacovigilance is the science of collecting, detecting, assessing, and monitoring data of marketed drugs in order to minimize or prevent adverse effects. Pharmacovigilance, a modernization and evolution of safety pharmacology, employs sophisticated state of the art approaches in the collection and analyses of data for marketed pharmaceutical products. Pharmacovigilance offers the promise of significant beneficial improvements in human health by providing more safe, effective and individually tailored therapeutics.
Loyola’s Department of Molecular Pharmacology & Neuroscience offers a 12-credit certificate program in Pharmacovigilance which can be completed in 1-year (full-time) or 2-years (part-time). This program is especially well suited for individuals who are planning careers in the pharmaceutical industry, public health sciences, or biomedical research. The certificate program is also suited for physicians, nurses, and scientists in epidemiology or therapeutic-related fields.
All courses consist of Asynchronous lectures and synchronous course meetings (early evening) and are flexible to allow students to take the courses from home and around daytime obligations
The US Department of Education requires any institution offering distance education/online programs to students outside of its home state to acquire authorization from the states in which students reside. Regulations vary from state to state. While Loyola University Chicago is authorized, exempt or pursuing authorization in most states, some restrictions apply. Please see our State Authorization page for the most up-to-date information.
Loyola University Chicago is registered as a private institution with the Minnesota Office of Higher Education pursuant to sections 136A.61 to 136A.71. Registration is not an endorsement of the institution. Credits earned at the institution may not transfer to all other institutions.